0.3991
0.96%
+0.0038
After Hours:
.40
0.0009
+0.23%
Palisade Bio Inc stock is currently priced at $0.3991, with a 24-hour trading volume of 131.32K.
It has seen a +0.96% increased in the last 24 hours and a +0.78% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $0.3882 pivot point. If it approaches the $0.4033 resistance level, significant changes may occur.
Palisade Bio Inc Stock (PALI) Financials Data
Palisade Bio Inc (PALI) Net Income 2023
PALI net income (TTM) was -$13.05 million for the quarter ending September 30, 2023, a -37.84% decrease year-over-year.
Palisade Bio Inc (PALI) Cash Flow 2023
PALI recorded a free cash flow (TTM) of -$11.69 million for the quarter ending September 30, 2023, a +10.80% increase year-over-year.
Palisade Bio Inc (PALI) Earnings per Share 2023
PALI earnings per share (TTM) was -$2.9213 for the quarter ending September 30, 2023, a -131.68% decline year-over-year.
Palisade Bio Inc Stock (PALI) Latest News
Palisade Bio to Present at Digestive Disease Week (DDW) 2024
GlobeNewswire Inc.
Palisade Bio Provides Corporate Update and Reiterates Guidance
GlobeNewswire Inc.
Correction Notice of Palisade Bio’s Press Release Announcing the Appointment of Clinical Advisory Board Members
GlobeNewswire Inc.
Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders
GlobeNewswire Inc.
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Palisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Million
GlobeNewswire Inc.
About Palisade Bio Inc
Palisade Bio, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress, such as results from reduced blood flow to the intestine, infections, and surgery. The company was founded in 2005 and is based in Carlsbad, California.
Cap:
|
Volume (24h):